These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32065426)
1. The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease. Singleton AB; Gasser T Mov Disord; 2020 Apr; 35(4):551-554. PubMed ID: 32065426 [No Abstract] [Full Text] [Related]
2. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
7. LRRK2 and the new era of Parkinson's disease research. The Lancet Neurology Lancet Neurol; 2016 Nov; 15(12):1195. PubMed ID: 27751534 [No Abstract] [Full Text] [Related]
8. Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease. Sanjari Moghaddam H; Aarabi MH Mov Disord; 2018 Dec; 33(12):1876. PubMed ID: 30452792 [No Abstract] [Full Text] [Related]
9. Targeting Leśniak RK; Nichols RJ; Smith M; Montine TJ Future Med Chem; 2022 Aug; 14(16):1167-1170. PubMed ID: 35730403 [No Abstract] [Full Text] [Related]
10. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203 [TBL] [Abstract][Full Text] [Related]